Updated May 27 at 4:27pm
Biotechnology
57 results total, viewing 11 - 20
To Amgen Inc.'s Senior Manager for Manufacturing Jimmy Fleming, the task of ensuring that he and his team are producing a quality product is of the utmost importance – professionally and personally. Fleming's sister is one of the more … more
(Updated, 9:20 p.m.) IlluminOss Medical has appointed Manny Avila as its new president and CEO. The developer of a minimally invasive system to repair bone fractures has been looking for a chief executive since former president and CEO Dirk Kuyper left in September 2014. more
EpiVax and French pharmaceutical company Ipsen recently announced a collaborative project to combat neurotoxins with novel biologic therapeutics. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
Tech Collective is looking for volunteers for GRRL Tech 2016 to assist with workshops and chaperone. Those who work in STEM – science, technology, engineering and math – fields are welcome to apply. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
(Updated 3:50 and 4:49 p.m.) ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people. more
Brown University leaders will break ground Thursday evening on an $88 million School of Engineering building that will focus on nanoscience and bioengineering research. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 Next »